Acute and Chronic Administration of the Branched-Chain Amino Acids Decreases Nerve Growth Factor in Rat Hippocampus

[1]  Victor A. McKusick,et al.  The Metabolic Basis of Inherited Disease , 2015 .

[2]  C. Vargas,et al.  Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect , 2013, International Journal of Developmental Neuroscience.

[3]  J. Quevedo,et al.  Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease , 2012, Behavioural Brain Research.

[4]  M. Bogo,et al.  Evaluation of Acetylcholinesterase in an Animal Model of Maple Syrup Urine Disease , 2012, Molecular Neurobiology.

[5]  C. Dutra-filho,et al.  In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease , 2011, Metabolic Brain Disease.

[6]  A. Terry,et al.  Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats , 2011, Physiology & Behavior.

[7]  M. Pérez,et al.  The Intra-Hippocampal Leucine Administration Impairs Memory Consolidation and LTP Generation in Rats , 2010, Cellular and Molecular Neurobiology.

[8]  G. Leipnitz,et al.  α-Ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain , 2010, Brain Research.

[9]  T. Sejnowski,et al.  NGF Is Essential for Hippocampal Plasticity and Learning , 2009, The Journal of Neuroscience.

[10]  Cunxian Song,et al.  Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion , 2009, Neuroscience Letters.

[11]  C. Callaghan,et al.  Deficits in LTP and recognition memory in the genetically hypertensive rat are associated with decreased expression of neurotrophic factors and their receptors in the dentate gyrus , 2009, Behavioural Brain Research.

[12]  G. Wegener,et al.  Reference genes for normalization: A study of rat brain tissue , 2008, Synapse.

[13]  F. Dal-Pizzol,et al.  Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration , 2008, Neuroscience Letters.

[14]  F. Dal-Pizzol,et al.  Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium , 2007, Journal of gastroenterology and hepatology.

[15]  H. Federoff,et al.  Proteolytic processing of proNGF is necessary for mature NGF regulated secretion from neurons. , 2007, Biochemical and biophysical research communications.

[16]  T. Hökfelt,et al.  Changes in brain cholinergic markers and spatial learning in old galanin-overexpressing mice , 2007, Brain Research.

[17]  A. Sitta,et al.  Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease , 2006, Metabolic Brain Disease.

[18]  C. Vargas,et al.  A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies , 2006, Journal of Neuroscience Methods.

[19]  F. Dal-Pizzol,et al.  N-acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. , 2005, Environmental research.

[20]  H. Çıralık,et al.  Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. , 2005, The Tohoku journal of experimental medicine.

[21]  L. Maffei,et al.  Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Wajner,et al.  Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats , 2005, Free radical research.

[23]  E. Snyder,et al.  Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord , 2004, The Journal of comparative neurology.

[24]  S. Schönberger,et al.  Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. , 2004, Molecular genetics and metabolism.

[25]  Michael E. Andrades,et al.  Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis* , 2004, Critical care medicine.

[26]  M. Wajner,et al.  Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. , 2003, Biochimica et biophysica acta.

[27]  M. Wajner,et al.  Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease , 2003, International Journal of Developmental Neuroscience.

[28]  M. Wajner,et al.  Creatine Kinase Activity from Rat Brain Is Inhibited by Branched-Chain Amino Acids in Vitro , 2003, Neurochemical Research.

[29]  Xiaoqing Yuan,et al.  Improvement of spatial learning and memory after adenovirus-mediated transfer of the nerve growth factor gene to aged rat brain. , 2002, Human gene therapy.

[30]  M. Wajner,et al.  Stimulation of Lipid Peroxidation in Vitro in Rat Brain by the Metabolites Accumulating in Maple Syrup Urine Disease , 2002, Metabolic Brain Disease.

[31]  C. Vargas,et al.  Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats , 2001, Neurochemistry International.

[32]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[33]  H. Mehmet,et al.  Primary Human Fibroblasts from a Maple Syrup Urine Disease Patient Undergo Apoptosis following Exposure to Physiological Concentrations of Branched Chain Amino Acids , 2000, Annals of the New York Academy of Sciences.

[34]  M. Wajner,et al.  Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease , 2000, Journal of the Neurological Sciences.

[35]  C. Vargas,et al.  Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises , 2000, Journal of Inherited Metabolic Disease.

[36]  D. Taylor,et al.  Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. , 2000, Molecular biology of the cell.

[37]  M. Wajner,et al.  Chronic early leucine administration induces behavioral deficits in rats. , 1999, Life sciences.

[38]  C. Vargas,et al.  Reduction of plasma concentrations of large neutral amino acids in patients with maple syrup urine disease during crises , 1999, Archives of disease in childhood.

[39]  R. Jope,et al.  Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells☆ , 1999, Neurobiology of Aging.

[40]  W. Anderson,et al.  In Vitro Effects of Oxygen-derived Free Radicals on Type I and Type II cAMP-Dependent Protein Kinases* , 1998, The Journal of Biological Chemistry.

[41]  Ted Abel,et al.  Positive and negative regulatory mechanisms that mediate long-term memory storage 1 Published on the World Wide Web on 13 January 1998. 1 , 1998, Brain Research Reviews.

[42]  J. van Oirschot,et al.  Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. , 1998, American journal of respiratory and critical care medicine.

[43]  H. R. Zielke,et al.  Effect of α-Ketoisocaproate and Leucine on the in Vivo Oxidation of Glutamate and Glutamine in the Rat Brain , 1997, Neurochemical Research.

[44]  E. Alleva,et al.  Nerve growth factor affects passive avoidance learning and retention in developing mice , 1996, Brain Research Bulletin.

[45]  M. Knipper,et al.  Short-term modulation of glutamatergic synapses in adult rat hippocampus by NGF. , 1994, Neuroreport.

[46]  D. Chitayat,et al.  Maple syrup urine disease: Interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination , 1992, Journal of Inherited Metabolic Disease.

[47]  T. Kameyama,et al.  Memory impairment and morphological changes in rats after continuous infusion of active fragment of anti-nerve growth factor-antibody. , 1991, Research communications in chemical pathology and pharmacology.

[48]  M. Greenberg,et al.  CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. , 1991, Science.

[49]  D. Kaplan,et al.  High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor , 1991, Nature.

[50]  P. Harper,et al.  Maple syrup urine disease (branched chain ketoaciduria). , 1990, The American journal of pathology.

[51]  R. Levi‐montalcini,et al.  The nerve growth factor 35 years later. , 1987, Science.

[52]  F. Gage,et al.  Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor , 1987, Nature.

[53]  H. Thoenen,et al.  Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor (NGF) without change in mRNANGF content , 1986, Neuroscience Letters.

[54]  A. Ross,et al.  Gene transfer and molecular cloning of the human NGF receptor. , 1986, Science.

[55]  M. Johnston,et al.  Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. , 1985, Science.

[56]  D. Tribble,et al.  Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease. , 1983, Biochemical and biophysical research communications.

[57]  M. Schwab,et al.  NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? , 1983, Brain research.

[58]  T. Kunishita,et al.  Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease. , 1983, The Japanese journal of experimental medicine.

[59]  J. Mowbray,et al.  CONTROL OF PYRUVATE AND β‐HYDROXYBUTYRATE UTILIZATION IN RAT BRAIN MITOCHONDRIA AND ITS RELEVANCE TO PHENYLKETONURIA AND MAPLE SYRUP URINE DISEASE , 1976, Journal of neurochemistry.

[60]  D. Goldstein,et al.  Dopamine‐β‐hydroxylase activity in human cerebrospinal fluid , 1976 .

[61]  L. E. Holt,et al.  MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY. , 1964, Pediatrics.

[62]  Melvin Lee,et al.  Influence of Alpha-Ketoacids on the Respiration of Brain in vitro. ∗ , 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[63]  L. Woolf,et al.  “Maple Syrup Urine Disease” , 1959, British medical journal.

[64]  J. Dancis,et al.  “Maple Syrup Urine Disease” , 1959, British medical journal.

[65]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[66]  L. Feksa,et al.  Effect of Leucine Administration to Female Rats During Pregnancy and Lactation on Oxidative Stress and Enzymes Activities of Phosphoryltransfer Network in Cerebral Cortex and Hippocampus of the Offspring , 2012, Neurochemical Research.

[67]  C. Caltagirone,et al.  Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[68]  M. Wajner,et al.  Inhibition of Brain Energy Metabolism by the Branched-chain Amino Acids Accumulating in Maple Syrup Urine Disease , 2007, Neurochemical Research.

[69]  M. Martín,et al.  N-acetyl-cysteine abolishes hydrogen peroxide-induced modification of eukaryotic initiation factor 4F activity via distinct signalling pathways. , 2006, Cellular signalling.

[70]  M. Sofroniew,et al.  Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.

[71]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[72]  H. R. Zielke,et al.  Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: alpha-ketoisocaproate infusion. , 1996, Developmental Neuroscience.

[73]  H. R. Zielke,et al.  Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: leucine infusion. , 1996, Developmental neuroscience.

[74]  S. De Flora,et al.  Chemopreventive properties and mechanisms of N‐acetylcysteine. The experimental background , 1995, Journal of cellular biochemistry. Supplement.

[75]  S. Flora,et al.  N‐acetyl‐l‐cysteine , 1993, Journal of cellular biochemistry. Supplement.

[76]  U. Wendel.  Disorders of Branched-Chain Amino Acid Metabolism , 1990 .

[77]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .